latest news in Celldex Therapeutics

Why Celldex Filed to Sell New Securities Despite Holding Over $650 Million in Cash

Why Celldex Filed to Sell New Securities Despite Holding Over $650 Million in Cash

Hampton, Saturday, 7 November 2026.
Despite beating earnings expectations and holding $650.3 million in capital, Celldex filed a universal shelf registration as zero quarterly revenue and heavy trial costs highlight ongoing dilution risks.